Clinical trial Recruiting at 1 site Observational Ages 18 to 55 Women only

Creating a decision aid tool for women with small, asymptomatic uterine leiomyomas

Official title: Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU

Run by Shenzhen Maternity & Child Healthcare Hospital · NCT05500118 · Data updated 2026-11-12

This study is trying to create a helpful tool for women with small, non-problematic uterine fibroids to make better decisions about their health.

More Leiomyoma, Uterine trials

Quick facts

Study typeObservational
Ages18 Years to 55 Years
SexWomen only
Enrollment120 (estimated)
SponsorShenzhen Maternity & Child Healthcare Hospital
Academic / other
Locations1 site (Shenzhen, Guangdong)
StatusRecruiting
StartedAugust 31, 2022
Main results expectedAugust 31, 2024
Study endsAugust 31, 2027
Registry record updatedAugust 12, 2022
Trial IDNCT05500118 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18-55 with asymptomatic small leiomyomas diagnosed via imaging.

Probably not a fit

Patients with symptomatic leiomyomas, those who have undergone myomectomy, or have other significant gynecological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop a decision aid tool for women diagnosed with asymptomatic small leiomyomas, focusing on improving clinical decision-making. A committee of designers, doctors, nurses, and patients will collaborate to identify factors influencing these decisions based on clinical guidelines and evidence-based medicine. The study will involve prospective trials to assess whether the decision aid tool enhances patients' decision-making efficacy and improves their reported outcomes. Participants will be women aged 18-55 with specific criteria regarding their leiomyoma diagnosis.

Why it matters

Potential benefit: If successful, this tool could empower patients to make more informed decisions regarding their treatment options for asymptomatic leiomyomas.

How similar studies have gone: While similar decision aid tools have been explored in other contexts, this specific approach for asymptomatic leiomyomas is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosis of leiomyoma: patients with leiomyoma diagnosed by imaging examinations (ultrasound and MRI) have no clinical symptoms;
2. Female with age in 18-55 years old;
3. The maximum diameter of a single leiomyoma is less than 5m, and the number does not exceed 10 by MRI;
4. No contraindications for sedation and analgesia;
5. Patients and their families agree to join this study, and can follow up on time.

Exclusion Criteria:

1. History of myomectomy, including transabdominal, laparoscopic, hysteroscopy, etc.;
2. History of connective tissue diseases or radiotherapy, especially abdominal radiotherapy;
3. With pregnancy, acute inflammation of the reproductive tract, or other gynecological benign and malignant diseases such as endometriosis and ovarian tumors;
4. The maximum diameter of leiomyoma is greater than or equal to 5cm;
5. Suspected malignant tumor, such as sarcoma;
6. Those with language communication barriers and unable to cooperate with sedative and analgesic programs;
7. Abdominal scarring, when diagnosed by ultrasound transabdominal scan, has obvious sound attenuation (more than 10mm range).

Where it's running

  • Shenzhen Maternal and Child Health Hospital
    Shenzhen, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.